Buy Insulent Corp. (PODD) on Weakness - Canaccord Genuity
Tweet Send to a Friend
Today Canaccord Genuity reiterated their Buy rating on Insulet Corporation (NASDAQ: PODD) but cut the price target to $24.50 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE